These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28087895)

  • 1. Crohn disease risk prediction-Best practices and pitfalls with exome data.
    Giollo M; Jones DT; Carraro M; Leonardi E; Ferrari C; Tosatto SCE
    Hum Mutat; 2017 Sep; 38(9):1193-1200. PubMed ID: 28087895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges.
    Daneshjou R; Wang Y; Bromberg Y; Bovo S; Martelli PL; Babbi G; Lena PD; Casadio R; Edwards M; Gifford D; Jones DT; Sundaram L; Bhat RR; Li X; Pal LR; Kundu K; Yin Y; Moult J; Jiang Y; Pejaver V; Pagel KA; Li B; Mooney SD; Radivojac P; Shah S; Carraro M; Gasparini A; Leonardi E; Giollo M; Ferrari C; Tosatto SCE; Bachar E; Azaria JR; Ofran Y; Unger R; Niroula A; Vihinen M; Chang B; Wang MH; Franke A; Petersen BS; Pirooznia M; Zandi P; McCombie R; Potash JB; Altman RB; Klein TE; Hoskins RA; Repo S; Brenner SE; Morgan AA
    Hum Mutat; 2017 Sep; 38(9):1182-1192. PubMed ID: 28634997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAGI4 Crohn's exome challenge: Marker SNP versus exome variant models for assigning risk of Crohn disease.
    Pal LR; Kundu K; Yin Y; Moult J
    Hum Mutat; 2017 Sep; 38(9):1225-1234. PubMed ID: 28512778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reports from the fifth edition of CAGI: The Critical Assessment of Genome Interpretation.
    Andreoletti G; Pal LR; Moult J; Brenner SE
    Hum Mutat; 2019 Sep; 40(9):1197-1201. PubMed ID: 31334884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.
    Niroula A; Vihinen M
    Hum Mutat; 2017 Sep; 38(9):1085-1091. PubMed ID: 28224672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are machine learning based methods suited to address complex biological problems? Lessons from CAGI-5 challenges.
    Savojardo C; Babbi G; Bovo S; Capriotti E; Martelli PL; Casadio R
    Hum Mutat; 2019 Sep; 40(9):1455-1462. PubMed ID: 31066146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods.
    Critical Assessment of Genome Interpretation Consortium
    Genome Biol; 2024 Feb; 25(1):53. PubMed ID: 38389099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer.
    Voskanian A; Katsonis P; Lichtarge O; Pejaver V; Radivojac P; Mooney SD; Capriotti E; Bromberg Y; Wang Y; Miller M; Martelli PL; Savojardo C; Babbi G; Casadio R; Cao Y; Sun Y; Shen Y; Garg A; Pal D; Yu Y; Huff CD; Tavtigian SV; Young E; Neuhausen SL; Ziv E; Pal LR; Andreoletti G; Brenner SE; Kann MG
    Hum Mutat; 2019 Sep; 40(9):1612-1622. PubMed ID: 31241222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blind prediction of deleterious amino acid variations with SNPs&GO.
    Capriotti E; Martelli PL; Fariselli P; Casadio R
    Hum Mutat; 2017 Sep; 38(9):1064-1071. PubMed ID: 28102005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretable prioritization of splice variants in diagnostic next-generation sequencing.
    Danis D; Jacobsen JOB; Carmody LC; Gargano MA; McMurry JA; Hegde A; Haendel MA; Valentini G; Smedley D; Robinson PN
    Am J Hum Genet; 2021 Sep; 108(9):1564-1577. PubMed ID: 34289339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
    Carraro M; Minervini G; Giollo M; Bromberg Y; Capriotti E; Casadio R; Dunbrack R; Elefanti L; Fariselli P; Ferrari C; Gough J; Katsonis P; Leonardi E; Lichtarge O; Menin C; Martelli PL; Niroula A; Pal LR; Repo S; Scaini MC; Vihinen M; Wei Q; Xu Q; Yang Y; Yin Y; Zaucha J; Zhao H; Zhou Y; Brenner SE; Moult J; Tosatto SCE
    Hum Mutat; 2017 Sep; 38(9):1042-1050. PubMed ID: 28440912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imputation-based assessment of next generation rare exome variant arrays.
    Martin AR; Tse G; Bustamante CD; Kenny EE
    Pac Symp Biocomput; 2014; ():241-52. PubMed ID: 24297551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective assessment of the evolutionary action equation for the fitness effect of missense mutations across CAGI-blinded contests.
    Katsonis P; Lichtarge O
    Hum Mutat; 2017 Sep; 38(9):1072-1084. PubMed ID: 28544059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants.
    Alirezaie N; Kernohan KD; Hartley T; Majewski J; Hocking TD
    Am J Hum Genet; 2018 Oct; 103(4):474-483. PubMed ID: 30220433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn's disease in a Chinese family study.
    Xu S; Zhou F; Tao J; Song L; Ng SC; Wang X; Chen L; Yi F; Ran Z; Zhou R; Xia B
    PLoS One; 2014; 9(6):e99807. PubMed ID: 24937328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing predictions of the impact of variants on splicing in CAGI5.
    Mount SM; Avsec Ž; Carmel L; Casadio R; Çelik MH; Chen K; Cheng J; Cohen NE; Fairbrother WG; Fenesh T; Gagneur J; Gotea V; Holzer T; Lin CF; Martelli PL; Naito T; Nguyen TYD; Savojardo C; Unger R; Wang R; Yang Y; Zhao H
    Hum Mutat; 2019 Sep; 40(9):1215-1224. PubMed ID: 31301154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense variant pathogenicity predictors generalize well across a range of function-specific prediction challenges.
    Pejaver V; Mooney SD; Radivojac P
    Hum Mutat; 2017 Sep; 38(9):1092-1108. PubMed ID: 28508593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Whole Exome Sequencing Data to Identify Clinically Relevant Pharmacogenomic Variants in Pediatric Inflammatory Bowel Disease.
    Mulder DJ; Khalouei S; Warner N; Gonzaga-Jauregui C; Church PC; Walters TD; Ramani AK; Griffiths AM; Cohn I; Muise AM
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00263. PubMed ID: 33512800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases.
    Kasak L; Hunter JM; Udani R; Bakolitsa C; Hu Z; Adhikari AN; Babbi G; Casadio R; Gough J; Guerrero RF; Jiang Y; Joseph T; Katsonis P; Kotte S; Kundu K; Lichtarge O; Martelli PL; Mooney SD; Moult J; Pal LR; Poitras J; Radivojac P; Rao A; Sivadasan N; Sunderam U; Saipradeep VG; Yin Y; Zaucha J; Brenner SE; Meyn MS
    Hum Mutat; 2019 Sep; 40(9):1373-1391. PubMed ID: 31322791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Crohn's disease signal from variome analysis.
    Wang Y; Miller M; Astrakhan Y; Petersen BS; Schreiber S; Franke A; Bromberg Y
    Genome Med; 2019 Sep; 11(1):59. PubMed ID: 31564248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.